Search Results 2221-2230 of 14806 for anti-TNF drugs

  1. Fibromyalgia and Chronic Fatigue Clinic in Minnesota - Overview

    It may involve ongoing education, medication and pain management strategies. What can you expect? Your clinic appointment begins with a one-hour evaluation with ...

  2. MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Must have anti-measles immunity as demonstrated by serum IgG anti ...

  3. Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer - Mayo Clinic

    This study is designed for patients with a cancer of the oropharynx (tonsils or base of tongue) caused by the HPV virus. Traditional treatment involves surgery ...

  4. Alectinib (Oral Route) Description and Brand Names - Mayo Clinic

    Alectinib belongs to the group of medicines called antineoplastics (cancer medicines). It works by interfering with the growth of cancer cells, which are ...

  5. Ranolazine (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Clinical Trials - Division of Infectious Diseases

    Drugs & Supplements A-Z · Health Books · Healthy ... treatment with antiviral therapies for ... The third aim is to measure SARS-CoV-2 anti-spike and anti ...

  7. Immuno-Epigenetics: William A. Faubion Jr.

    Faubion's lab seeks to discover, identify and develop individualized treatments to improve treatment options for people with inflammatory bowel disease (IBD).

  8. Tiopronin (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Thiola; Thiola EC. Descriptions. Tiopronin is used together ...

  9. Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin for First-Line Treatment of Patients With Advanced NSCLC Without Actionable Genomic Alterations - Mayo Clinic

    - Persistent toxicities caused by previous anti-cancer therapy not yet improved to Grade ≤ 1 or baseline (with exceptions) - Active or prior documented ...

  10. No specific characteristics associated with poor response to elagolix with add-back therapy in patients with uterine fibroids - Mayo Clinic

    For patients with uterine fibroids whose heavy menstrual bleeding was unresponsive to elagolix with add-back therapy — a medication alternative to ...